Hot penny stocks... don't get burned
   

Profile for Acorda Therapeutics (ACOR)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
Profile for Acorda Therapeutics Inc.  (ACOR) 
$ 28.01      -0.14 (-0.50%) Volume: 81.27 k 10:48 AM EDT Aug 21, 2008
Business Description:
A biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury & other disorders of the central nervous system.
Address:    15 Skyline Drive, Hawthorne, NY 10532
Telephone:   
(914) 347-4300
 
Website:   
www.acorda.com
Facsimile:   
(914) 347-4560
Email:   
investorrelations@acorda.com
Details
CEO:   
Dr. Ron Cohen, M.D.
Employees:   
144
Market Cap:   
914.82 m
Issue Type:   
Common Stock
Auditor:    KPMG LLP
Last Audit:    Unqualified
Indices:    Russell 2000
Industry Classifications
Sector:   
Healthcare
CIK:   
0001008848
Industry:    Drugs
NAICS:    Biological Product (except Diagnostic) Manufacturing (325414)
QM ID:    Biotechnology (515)
SIC:    Biological Products, Except Diagnostic Substances (2836)
Profitability
Management Effectiveness
Gross Margin:   
75.90
Return on Equity:   
 
EBIT Margin:   
 
Return on Capital:   
-35.10
Profit Margin:   
 
Return on Assets:   
-23.90
Share Statistics
Outstanding:   
32.66 m
Float:   
32.27 m
Short Interest:   
6.48 m (as of 7/28/08)
Short Int Ratio:   
12.20
% of Float:   
20.10%
Non-Corp. Insider Hold'gs:   
1.20% (as of 6/1/08)
Bought Prev 3 Mo:   
169.32 k
Sold Prev 3 Mo:   
411.25 k
Institution Hold'gs:   
  (as of 7/1/08)
Total Held:   
35.83 m
Institutions:   
111
Bought Prev Mo:   
7.93 m
Sold Prev Mo:   
2.31 m

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, profiles by Hemscott.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for ACOR stock. Download ACOR report.
Research Report
Get the full report for FREE
Date:May 12, 2008
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download ACOR report
  
Example preview: Research report for Acorda Therapeutics (ACOR) Research report for Acorda Therapeutics (ACOR) Research report for Acorda Therapeutics (ACOR) Research report for Acorda Therapeutics (ACOR)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

SPKL shot up 32%


From: OTC Journal
Added: 22 Sep, 2007

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Acorda Therapeutics
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.